Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 December 2023 | Story Anthony Mthembu | Photo SUPPLIED
Albertus Engelbrecht
Albertus Engelbrecht: Lecturer in Singing and Coordinator of Vocal Studies at the Odeion School of Music.

The University of the Free State (UFS) is gearing up to honour a new group of graduates during the upcoming graduation ceremonies on 7-8 December 2023. Among the distinguished individuals set to grace the stage is Albertus Engelbrecht, Coordinator of Vocal Studies at the Odeion School of Music and an internationally recognised opera singer with a career spanning over two decades.

Engelbrecht has achieved a significant milestone, completing his PhD thesis titled “The Journey of a Versatile Singer”. On 7 December 2023, he will formally receive his qualification, marking the culmination of a seven-year academic journey. Reflecting on this achievement, Engelbrecht expressed his relief, stating, “It’s all still so surreal, but I think that the moment I walk onto that stage, then, will it only sink in.’’  

The journey of a versatile singer

His thesis is an auto-ethnographic study that delves into the preparation and performance of five different styles and genres of Western art music. This unique approach includes a practical component, as he actively participated in five different concerts or performances, ultimately contributing to his research. He shared his motivation, stating, ‘’I was investigating how it would be possible to sing different kinds of Western art music styles and genres. The idea came from my professional experience, where I found that to become a successful opera and concert singer, it’s better for one to be able to do different styles and genres.’’  

Looking ahead, Engelbrecht envisions his research making a meaningful impact on the development of emerging singers. He aspires to shape the future of vocal education, stating, “I hope that my contribution leads to new knowledge not only for singers but for their teachers and vocal coaches. This is so that they can approach music in the way it is written, and to find ways which make the music speak the best way it can. In this way, singers can be more versatile.’’  

Future plans

Post-graduation, Engelbrecht has ambitious plans to further his growth within the industry. Expressing his goals, he said, ‘’I would like to grow not just as a performing artist but as a researcher too.” Currently collaborating with his former supervisor on a research project focusing on performance analysis, Engelbrecht aims to delve deeper into the research aspect of his profession. Additionally, as a Lecturer of Singing at the UFS, he looks forward to engaging in more performing projects with his students.

In recognition of Albertus Engelbrecht’s remarkable achievement, the UFS community congratulates him on this significant milestone. His dedication to the field of vocal studies and commitment to fostering versatility in music is truly commendable. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept